| GC47724-10mg |
|
474943-92-5 |
N,N-dimethyl Sphingosine (d17:1)
|
0 |
C19H39NO2 |
|
|
|
| GC47724-5mg |
|
474943-92-5 |
N,N-dimethyl Sphingosine (d17:1)
|
0 |
C19H39NO2 |
|
|
|
| GC47724-1mg |
|
474943-92-5 |
N,N-dimethyl Sphingosine (d17:1)
|
0 |
C19H39NO2 |
|
|
|
| GC47723-25mg |
|
17267-46-8 |
N,N-dimethyl Sphinganine (d18:0)
|
0 |
C20H43NO2 |
|
|
|
| GC47723-10mg |
|
17267-46-8 |
N,N-dimethyl Sphinganine (d18:0)
|
0 |
C20H43NO2 |
|
|
|
| GC47723-5mg |
|
17267-46-8 |
N,N-dimethyl Sphinganine (d18:0)
|
0 |
C20H43NO2 |
|
|
|
| GC47722-5mg |
|
— |
N,N-dimethyl Heptylone (hydrochloride)
|
0 |
C16H23NO3.HCl |
|
|
|
| GC47722-1mg |
|
— |
N,N-dimethyl Heptylone (hydrochloride)
|
0 |
C16H23NO3.HCl |
|
|
|
| GC47721-5mg |
|
— |
N,N-dihexyl Sphingosine (d18:1/6:0/6:0)
|
0 |
C30H61NO2 |
|
|
|
| GC47720-500μg |
|
30414-15-4 |
N,N’-bis(2,3-Dihydroxybenzoyl)-O-L-seryl-L-serine
|
0 |
C20H20N2O11 |
|
|
|
| GC47720-100μg |
|
30414-15-4 |
N,N’-bis(2,3-Dihydroxybenzoyl)-O-L-seryl-L-serine
|
0 |
C20H20N2O11 |
|
|
|
| GC47719-500μg |
|
73410-35-2 |
N,N’-bis(2,3-Dihydroxybenzoyl)-O-L-seryl-L-dehydroalanine
|
0 |
C20H18N2O10 |
|
|
|
| GC47719-100μg |
|
73410-35-2 |
N,N’-bis(2,3-Dihydroxybenzoyl)-O-L-seryl-L-dehydroalanine
|
0 |
C20H18N2O10 |
|
|
|
| GC47717-1g |
|
146474-00-2 |
N-(2-Aminoethyl)maleimide (trifluoroacetate salt)
|
0 |
C6H8N2O2.CF3COOH |
|
|
|
| GC47717-500mg |
|
146474-00-2 |
N-(2-Aminoethyl)maleimide (trifluoroacetate salt)
|
0 |
C6H8N2O2.CF3COOH |
|
|
|
| GC47717-250mg |
|
146474-00-2 |
N-(2-Aminoethyl)maleimide (trifluoroacetate salt)
|
0 |
C6H8N2O2.CF3COOH |
|
|
|
| GC47716-1mg |
|
120243-02-9 |
|
0 |
C20H24N2O7 |
|
|
|
| GC47715-5mg |
|
1334532-25-0 |
Myristoyl-L-carnitine-d3 (chloride)
|
0 |
C21H39D3NO4.Cl |
|
|
|
| GC47715-1mg |
|
1334532-25-0 |
Myristoyl-L-carnitine-d3 (chloride)
|
0 |
C21H39D3NO4.Cl |
|
|
|
| GC47714-5mg |
|
— |
Myristoyl-L-carnitine-14,14,14-d3 (chloride)
|
0 |
C21H39D3NO4.Cl |
|
|
|
